Jan Mäkelä plans to use new product launches and the breadth of the US business to offset an expected revenue shortfall of EUR 60-80m.
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is a corporate revenue strategy story with no clinical or patient-care implications.
Supply-chain shifts at a major hearing aid component maker could affect product availability and pricing downstream for manufacturers and, ultimately, clinics.
- 01WSA CEO Jan Mäkelä attributes the loss of a key US client to a client-side decision, not WSA performance.
- 02The revenue shortfall is estimated at EUR 60–80 million.
- 03WSA plans to offset losses through new product launches and broader US market penetration.
- 04No specific details on replacement clients or product timelines are given.
- 05No clinical data or patient outcomes are involved.
WSA expects a EUR 60–80 million revenue shortfall from losing a key US client.
quotesupportedNew product launches and US market breadth will offset the revenue shortfall.
opinionunclear